Table 4.
Functional and pathway enrichment analysis of hsa-miR-182-5p-related differentially expressed genes in ovarian cancer
| Term | Description | Count | P-Value | FDR |
|---|---|---|---|---|
| Cellular components | ||||
| GO:0005634 | nucleus | 120 | 4.67E-08 | 6.23E-05 |
| GO:0005737 | cytoplasm | 108 | 1.38E-05 | 1.85E-02 |
| Molecular function | ||||
| GO:0005515 | protein binding | 173 | 1.58E-07 | 2.23E-04 |
| GO:0043565 | sequence-specific DNA binding | 23 | 1.18E-05 | 1.67E-02 |
| Biological processes | ||||
| GO:0030198 | extracellular matrix organization | 14 | 1.00E-05 | 1.70E-02 |
| KEGG pathway | ||||
| hsa05200 | Pathways in cancer | 22 | 1.93E-06 | 2.41E-03 |
| hsa04510 | Focal adhesion | 15 | 8.20E-06 | 1.02E-02 |
| hsa04512 | ECM-receptor interaction | 10 | 1.38E-05 | 1.72E-02 |
FDR false discovery rate, Count the number of enriched genes in each term, GO gene ontology, KEGG Kyoto Encyclopedia of Genes and Genomes